atheriosclerotic cardiovascular disease
Conditions
Interventions
Group 1 :
Group 2:
Sponsors
Chinese PLA General Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Age > 18 years old; 2. The subject himself or his legal representative has been informed of the research protocol and various relevant regulations in detail, can ensure full compliance and sign the informed consent; 3. The subjects in the healthy group (Group H) are in good health and have no history of hypertension, diabetes, hyperlipidemia, thyroid disease, etc.; 4. Three high group subjects (PF group) complicated with hypertension and/or diabetes and/or hyperlipidemia.
Exclusion criteria
Exclusion criteria: 1. Previous diagnosis of coronary heart disease, old myocardial infarction, stroke, after PCI, after CABG; 2. Tumor; 3. Thyroid disease; 4. Severe anemia; 5. Severe hepatic insufficiency; 6. Severe renal insufficiency; 7. Cannot independently cooperate to complete the use of wearable devices and data collection.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| vital signs;body composition;routine blood test;blood biochemical index;PPG, ACC and ECG data based on smart wearable devices;CGM data based on blood glucose meters;24-hour ambulatory blood pressure;24-hour dynamic ECG;non-invasive PWV examination; | — |
Countries
China
Contacts
Public ContactYundai Chen
Senior Department of Cardiology, Chinese PLA General Hospital
Outcome results
None listed